However, treatment with the PAR-1 antagonist SCH 79797 significantly inhibited Cyr61 synthesis in fibroblasts but not in myofibroblasts, where the observed decrease did not reach statistical significance.
← all excerpts
Thrombin alters the synthesis and processing of CYR61/CCN1 in human corneal stromal fibroblasts and myofibroblasts through multiple distinct mechanisms.
1
—
—